Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

3 Biotech Stocks Able to Weather an Unstable Administration

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"3 Biotech Stocks Able to Weather an Unstable Trump Administration" ALT"3 Biotech Stocks Able to Weather an Unstable Trump Administration"February 10, 2017By Mark Terry, BioSpace.com Breaking News Staff...…

Continue Reading3 Biotech Stocks Able to Weather an Unstable Administration

Why Intercept Pharma Stock Jumped Nearly 10% On Friday After Providing Phase III Update

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks.jpg" NAME"Why Intercept Stock Jumped Nearly 10% On Friday After Providing Phase III Update" ALT"Why Intercept Stock Jumped Nearly 10% On Friday After Providing Phase III Update"February 10, 2017By…

Continue ReadingWhy Intercept Pharma Stock Jumped Nearly 10% On Friday After Providing Phase III Update

Seattle Genetics, Immunomedics Ink $2 Billion Tumor Drug Deal

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-deal3.jpg" NAME"Seattle Genetics, Immunomedics Ink $2 Billion Tumor Drug Deal" ALT"Seattle Genetics, Immunomedics Ink $2 Billion Tumor Drug Deal"February 10, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR... Source: BioSpace

Continue ReadingSeattle Genetics, Immunomedics Ink $2 Billion Tumor Drug Deal